down arrow

PolyPeptide Group AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH1110760852
CHF
24.80
0.25 (1.02%)

Dec 15

SWX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Kuros Biosciences Ltd.
PolyPeptide Group AG
Molecular Partners AG
Why is PolyPeptide Group AG ?
1
Weak Long Term Fundamental Strength with a -161.75% CAGR growth in Operating Profits over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 3.61
  • The company has been able to generate a Return on Equity (avg) of 6.23% signifying low profitability per unit of shareholders funds
2
Negative results in Jun 25
  • PRE-TAX PROFIT(Q) At CHF -29.24 MM has Fallen at -147.02%
  • NET PROFIT(Q) At CHF -24.99 MM has Fallen at -128.25%
  • INTEREST(Q) Highest at CHF 16.78 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -10.09%, its profits have fallen by -19.4%
4
Below par performance in long term as well as near term
  • Along with generating -10.09% returns in the last 1 year, the stock has also underperformed Switzerland SMI in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is PolyPeptide Group AG for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
PolyPeptide Group AG
-10.63%
-0.45
52.49%
Switzerland SMI
10.0%
0.63
15.85%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
4.34%
EBIT Growth (5y)
-161.75%
EBIT to Interest (avg)
3.61
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
0.74
Tax Ratio
7.63%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.85%
ROE (avg)
6.23%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.53
EV to EBIT
-82.26
EV to EBITDA
33.21
EV to Capital Employed
2.50
EV to Sales
2.27
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.04%
ROE (Latest)
-10.58%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -170.87% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 5.4%

-9What is not working for the Company
PRE-TAX PROFIT(Q)

At CHF -29.24 MM has Fallen at -147.02%

NET PROFIT(Q)

At CHF -24.99 MM has Fallen at -128.25%

INTEREST(Q)

Highest at CHF 16.78 MM

Here's what is working for PolyPeptide Group AG
Debtors Turnover Ratio
Highest at 5.4%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -170.87% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at CHF 17.1 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (CHF MM)

Here's what is not working for PolyPeptide Group AG
Pre-Tax Profit
At CHF -29.24 MM has Fallen at -147.02%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CHF MM)

Net Profit
At CHF -24.99 MM has Fallen at -128.25%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CHF MM)

Interest
Highest at CHF 16.78 MM
in the last five periods and Increased by 98.24% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CHF MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."